Everence Capital Management Inc. Invests $393,000 in DaVita Inc. (NYSE:DVA)

Everence Capital Management Inc. purchased a new stake in shares of DaVita Inc. (NYSE:DVA) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 3,750 shares of the company’s stock, valued at approximately $393,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. State of Michigan Retirement System lifted its stake in shares of DaVita by 0.6% during the fourth quarter. State of Michigan Retirement System now owns 15,939 shares of the company’s stock worth $1,670,000 after purchasing an additional 100 shares in the last quarter. Treasurer of the State of North Carolina lifted its stake in shares of DaVita by 0.5% in the third quarter. Treasurer of the State of North Carolina now owns 24,503 shares of the company’s stock worth $2,316,000 after acquiring an additional 123 shares in the last quarter. Veritable L.P. lifted its stake in shares of DaVita by 4.6% in the first quarter. Veritable L.P. now owns 3,026 shares of the company’s stock worth $245,000 after acquiring an additional 133 shares in the last quarter. Captrust Financial Advisors lifted its stake in shares of DaVita by 3.7% in the first quarter. Captrust Financial Advisors now owns 3,860 shares of the company’s stock worth $437,000 after acquiring an additional 139 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its stake in shares of DaVita by 3.2% in the third quarter. Daiwa Securities Group Inc. now owns 4,631 shares of the company’s stock worth $438,000 after acquiring an additional 144 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insider Activity

In other news, CEO Javier Rodriguez sold 67,603 shares of the stock in a transaction on Monday, February 26th. The stock was sold at an average price of $126.11, for a total value of $8,525,414.33. Following the completion of the sale, the chief executive officer now owns 488,697 shares in the company, valued at $61,629,578.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO Michael David Staffieri sold 29,488 shares of the company’s stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $119.81, for a total value of $3,532,957.28. Following the transaction, the chief operating officer now directly owns 37,687 shares of the company’s stock, valued at $4,515,279.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the transaction, the chief executive officer now directly owns 488,697 shares in the company, valued at $61,629,578.67. The disclosure for this sale can be found here. Insiders sold 134,540 shares of company stock worth $16,551,071 over the last quarter. Corporate insiders own 1.40% of the company’s stock.

DaVita Price Performance

Shares of NYSE:DVA opened at $126.11 on Friday. DaVita Inc. has a one year low of $71.51 and a one year high of $141.54. The stock has a fifty day moving average of $130.32 and a 200-day moving average of $108.79. The company has a market capitalization of $11.06 billion, a PE ratio of 17.04, a price-to-earnings-growth ratio of 1.14 and a beta of 1.04. The company has a debt-to-equity ratio of 6.65, a quick ratio of 1.13 and a current ratio of 1.19.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, February 13th. The company reported $1.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.53 by $0.34. The company had revenue of $3.15 billion during the quarter, compared to analyst estimates of $3.01 billion. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.11 earnings per share. As a group, equities analysts anticipate that DaVita Inc. will post 9.23 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DVA has been the topic of several recent analyst reports. UBS Group boosted their price target on DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Barclays began coverage on DaVita in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price target on the stock. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a research note on Wednesday, February 7th. Truist Financial upped their price objective on DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Tuesday, February 20th. Finally, StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, DaVita currently has a consensus rating of “Moderate Buy” and a consensus price target of $118.50.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.